Development and validation of a documentation of therapy aims, content and outcome measures to improve mobility in people with multiple sclerosis during inpatient neurological rehabilitation in Austria

Development and validation of a documentation of therapy aims, content and outcome measures to improve mobility in people with multiple sclerosis during inpatient neurological rehabilitation in Austria - ZIERMS

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00030391

Enrollment

600

Registered

2022-09-30

Start date

2022-10-17

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physiotherapists, sports scientists and physicians who are in involved in the study G35

Interventions

Group 1: Routinely over a study period of 4 weeks: 1x collection of mobility-related therapy goals using presentation of the ICF mobility categories

2x mobility assessment using the "MS Mobility Core Set" consisting of a 2-Minute Walk Test (2MTW), Timed 25-Foot Walk (T25FW), 5-Repetition Sit to Stand Test (5-STS), Twelve- Item Multiple Sclerosis W

documentation of individual physiotherapy sessions carried out as part of the multidisciplinary inpatient rehabilitation, according to the service catalogue of the Austrian Pension Insurance Instituti

1x evaluation of the IK-ZIERMS for its practicability and suitability for everyday use using the System Usability Scale (SUS)

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Males and females with a diagnosis of MS according to the revised McDonald criteria (Thompson et al 2018), regardless of disease phenotype or ethnicity - Age = 18 years - very good knowledge of German - Primary rehabilitation goal: improvement of mobility according to the WHO International Classification of Functioning, Disability and Health (ICF) - Ambulatory (Expanded Disability Status Scale (EDSS) Score 0 - 6.5; Kurtzke, 1983)

Exclusion criteria

Exclusion criteria: - Recent relapse of MS (< 30 days before study inclusion) - pregnancy - Comorbidity that, at the discretion of the investigator, prevents participation in the study (e.g.: malignant disease, dementia, other neurological or psychiatric diseases)

Design outcomes

Primary

Measure	Time frame
Evaluation of the effects of an active therapy intervention on mobility in people with MS in a multidisciplinary inpatient neurological rehabilitation setting.	—

Secondary

Measure	Time frame
1 Recording and evaluation of mobility-related therapy goals of MmMS in the context of a multidisciplinary inpatient neurological rehabilitation. 2 Review of an intervention catalogue (IK-ZIERMS) for its practicability and suitability for everyday use.	—

Countries

Austria

Contacts

Public ContactAndreas Wanitschek

Reha Zentrum Münster Betriebs GmbH

andreas.wanitschek@reha-muenster.at+435337200046204

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026